RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

350.60

337.63

301.36

263.72

219.38

Operating profit

74.50

85.00

69.53

57.57

37.61

Interest

0.25

0.32

0.17

0.19

0.22

Gross profit

84.02

88.99

73.00

59.83

39.26

EPS (Rs)

38.18

18.72

29.00

23.09

13.39

Other income

9.77

4.31

3.64

2.45

1.87

Stock adjustment

-10.00

4.78

-2.62

-0.93

-17.72

Raw material

64.76

53.18

67.77

43.44

48.27

Power and fuel

-

-

-

-

-

Employee expenses

69.86

65.83

66.38

55.00

50.60

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

151.48

128.84

100.30

108.64

100.62

Provisions made

-

-

-

-

-

Depreciation

10.36

10.60

8.44

7.70

7.71

Taxation

21.74

20.13

16.60

13.95

9.40

Net profit / loss

63.14

30.96

47.96

38.18

22.15

Extra ordinary item

11.22

-27.30

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.23

13.23

13.23

13.23

13.23

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

21.25

25.18

23.07

21.83

17.14

GPM (%)

23.31

26.03

23.93

22.48

17.74

NPM (%)

17.52

9.05

15.72

14.34

10.01